Medicinal plants have been used in healthcare since time immemorial. Studies have been carried out globally to verify their efficacy and some of the findings have led to the production of plant-based medicines. The global market value of medicinal plant products exceeds $100 billion per annum. This paper discusses the role, contributions and usefulness of medicinal plants in tackling the diseases of public health importance, with particular emphasis on the current strategic approaches to disease prevention. A comparison is drawn between the 'whole population' and 'high-risk' strategies. The usefulness of the common-factor approach as a method of engaging other health promoters in propagating the ideals of medicinal plants is highlighted. The place of medicinal plants in preventing common diseases is further examined under the five core principles of the Primary Health Care (PHC) approach. Medicinal plants play vital roles in disease prevention and their promotion and use fit into all existing prevention strategies. However, conscious efforts need to be made to properly identify, recognise and position medicinal plants in the design and implementation of these strategies. These approaches present interesting and emerging perspectives in the field of medicinal plants. Recommendations are proposed for strategising the future role and place for medicinal plants in disease prevention.
Introduction
The emphasis on the use of medicinal plants had hitherto been placed on the treatment rather than prevention of diseases. However, there exists in the literature considerable report in recent times on research work on the use of medicinal plants and their constituents in disease prevention. A World Health Organisation (WHO) Expert Group defined Traditional Medicine as the sum total of all knowledge and practices, whether explicable or not, used in diagnosis, prevention and elimination of physical, mental, or social imbalance and relying exclusively on practical experience and observation handed down from generation to generation, whether verbally or in writing (WHO, 1976) . For Africa, this may be extended further by including an expression, such as 'while bearing in mind the original concept of nature which includes the material world, the sociological environment whether living or dead and the metaphysical forces of the universe'.
Over 90% of traditional medicine recipes/remedies contain medicinal plants but this paper will address, specifically, the medicinal plants that have been implicated with preventive measures in disease control strategies. However, it must be noted that only a very thin divide exists between treatment and prevention in some cases. A quick example is the fact that by treating mild elevation of blood pressure renal disease can be prevented.
What is a medicinal plant?
A medicinal plant is any plant which, in one or more of its organs, contains substances that can be used for therapeutic purposes or which are precursors for the synthesis of useful drugs. This description makes it possible to distinguish between medicinal plants whose therapeutic properties and constituents have been established scientifically, and plants that are regarded as medicinal but which have not yet been subjected to a thorough scientific study.
A number of plants have been used in traditional medicine for many years. Some do seem to work although there may not be sufficient scientific data (double-blind trials, for example) to confirm their efficacy. Such plants should qualify as medicinal plants. The term 'crude drugs of natural or biological origin' is used by pharmacists and pharmacologists to describe whole plants or parts of plants which have medicinal properties. A definition of medicinal plants for the purpose of this presentation should include the following (Sofowora 2008; Evans, 2008) : (a) plants or plant parts used medicinally in galenical preparations (e.g. decoctions, infusions, etc.) e.g. Cascara bark; (b) plants used for extraction of pure substances either for direct medicinal use or for the hemi-synthesis of medicinal compounds (e.g. hemi-synthesis of sex hormones from diosgenin obtained from Dioscorea yams); (c) food, spice, and perfumery plants used medicinally, e.g. A Presidential Initiative Committee on the Development, Promotion, and Commercialisation of Nigerian Herbal Medicinal Products was inaugurated on 30th May 2006 and was given a target of US$1billion sales of medicinal plants and its products within 10 years for Nigeria. Based on current research and financial investments, medicinal plants will, seemingly, continue to play an important role as a health aid (Hoareau and DaSilva, 1999) . The use of traditional medicine and medicinal plants in most developing countries, as a normative basis for the maintenance of good health, has been widely observed (UNESCO, 1996) . Furthermore, an increasing reliance on the use of medicinal plants in the industrialised societies has been traced to the extraction and development of several drugs and chemotherapeutics from these plants as well as from traditionally used rural herbal remedies (UNESCO, 1998). Moreover, in these societies, herbal remedies have become more popular in the treatment of minor ailments, and also on account of the increasing costs of personal health maintenance. Indeed, the market and public demand has been so great that there is a great risk that many medicinal plants today face either extinction or loss of genetic diversity.
Preventive strategies
Health promotion, disease prevention and chronic disease management are proactive approaches to health care that stresses prevention at different points along the health care continuum. Health promotion and disease prevention strategies focus on keeping people well and preventing diseases from occurring. These strategies are referred to as primary prevention activities. Prevention is categorised into three levels (Commission on Chronic Illness, 1957):
Primary Prevention, which seeks to decrease the number of new cases of a disorder or illness. At this level of prevention we have:  Health promotion/education, and  Specific protective measures (such as immunisation) (2) Secondary Prevention, which seeks to lower the rate of established cases of a disorder or illness in the population (prevalence). This level essentially involves measures that ensure early diagnosis (such as screening) and prompt management (3)
Tertiary Prevention, which seeks to decrease the amount of disability associated with an existing disorder. This level involves:  Disability limitation and  Rehabilitation The secondary and tertiary prevention activities focus on maintaining the health of individuals with chronic conditions, delaying progression of their conditions, and preventing complications.
Disease prevention should focus on strategies that reduce the risk of disease, identify risk factors, or detect disease in its early, most treatable stages. Examples of disease prevention activities include well-baby visits, immunisations, calcium and Vitamin D supplements to reduce the risk of osteoporosis, blood pressure and cholesterol assessments during annual health exams, and screening for illnesses such as breast, cervical, colorectal and prostate cancer (Family Health Teams, 2006) . Public health, diet, food production and the environment are deeply interrelated, and understanding these relationships is crucial in pursuing a liveable future. Sometimes therefore, there is only a thin line between treatment and prevention of certain diseases. For example, treatment of mild hypertension will prevent many chronic renal diseases. This is also true for obesity, cancers, coronary heart diseases (CHDs) as well as diabetes and its sequelae, though these are noncommunicable diseases.
The burden of healthcare and its human and financial resources requirement
In developing countries all over the world, large numbers of people die daily of preventable or curable diseases because of the lack of even simple health care. Diseases in these countries are often associated with malnutrition. As a result, those that do survive often never recover completely from the effects. The developing world is not a homogenous entity, but is made up of a variety of widely differing countries and areas which are at different stages of development. Nevertheless, these developing countries have certain features in common, including extremely limited resources, poor communications, vast distances, low levels of education, and individual and community poverty. These factors act together to keep these countries in a perpetual state of poverty. Yet, their populations continue to rise, especially in the rural regions which usually account for about 80 per cent of the total population. Another special characteristic of the developing world is the nomadic lifestyle of some of its people. Some 50 to 100 million nomads have been estimated to be present in the world, and 90 per cent of these live in Africa or Asia. Nomads have their own needs and problems peculiar to their lifestyle. Because of their constant movement and dispersion it is difficult for conventional health services to reach these people. The striking difference between the developed and the developing world in terms of health care is reflected in the differing life expectancy of their populations. For example, according to WHO (2012) , in 2009 the life expectancy at birth was estimated at 51 years in Angola and Burkina Faso, while for Malawi it was 47 years (African countries) compared with 80 years in the United Kingdom, USA and Austria. Although the situation is improving in some African countries, this gap is still wide. Twenty-six African countries are ranked among the 'Low Income Group', 17 in the 'Lower Middle Income Group' and 9 in the 'Upper Middle Income Group', while only Equatorial Guinea is ranked in the 'High Income Group' (WHO, 2012). Several of the people in Africa earn less than US$2 per day.
Any strategy for disease prevention in the developing countries, especially in Africa, must take these socioeconomic factors into account. With the abundant biodiversity of plants in the African Region and the relative lower cost of using plant derived medicines instead of processed synthetic drugs, medicinal plants should have a role to play in disease prevention strategies in Africa.
Strategies planned for traditional medicine development (First decade and second decade for Traditional Medicine in Africa)
For WHO, the main principles of the strategy for developing traditional medicine (TM) globally were thus:  Policy: Integrate TM/CAM with national health care systems, as appropriate, by developing and implementing national TM/CAM policies and programmes  Safety, efficacy and quality: Promote the safety, efficacy and quality of TM/CAM by expanding the knowledgebase on TM/CAM, and by providing guidance on regulatory and quality assurance standards 
Global Disease Burden
Diseases have been grouped as communicable or non-communicable based on the involvement or otherwise of a transmissible biologic disease causing agent. Until recently, communicable diseases (CDs) were the major causes of ill-health and deaths in the developing (low and middle resource) countries while non-communicable diseases were prevalent in the developed (high resource) countries, where improvement in living conditions and widespread deployment of technology had brought the CDs under control. However, the optimism that communicable diseases would be less of a health problem in the developed countries appears to have been misplaced with the appearance of new infectious diseases and re-emergence of older disease agents. Similarly, non-communicable diseases are already a major cause of morbidity and mortality as a consequence of globalisation and changing lifestyle in developing countries. Globally therefore, NCDs and CDs account for about equal quantities of morbidity and mortality, thus making all countries to currently face the double disease burden. The overall picture is, however, graver for low and middle income countries in terms of the health and socio-economic impacts.
For example, estimates of projected causes of all deaths for the African Region indicate that injuries and chronic communicable diseases accounted for 30% of all deaths for 2005. (Figure 1 )
Medicinal plants and disease prevention Strategies for the Prevention of Communicable diseases
Three core approaches -surveillance, outbreak investigations and immunisation -are fundamental to the prevention of communicable diseases. While medicinal plants may appear to have limited role in these approaches, several medicinal plants and traditional medicines derived from them have been used to enhance immune response to several disease agents (Di Pierro et al., 2012; Ramakrishna et al., 2011) .
Strategies for Prevention of Non-Communicable Diseases
The The 'whole population' and 'high-risk' strategies Two main types of approaches have been advocated in tackling major public health problems. The wholepopulation strategy targets the community as a whole to control the occurrence of new diseases in the population. The highrisk strategy on the other hand aims to identify individuals most at risk for a disease or outcome and then target preventive efforts at that group. These were first defined by Geoffrey Rose (Rose, 1985) . In promoting the use of medicinal plants in disease prevention, the whole-population strategy will have the global community as the target, whereas the high-risk strategy may focus on rural communities, especially in the developing countries. It may also on the other hand wish to focus on refining medicinal plants for use in specific disease conditions that presently defy conventional treatment, such as cancer, HIV infection and AIDS.
Utilising the Common Factor approach
The common risk factor approach aims at bringing together several health promoters working on eliminating common-risk factors as a way of preventing diseases. (Sheiham and Walt, 2000) Poor Diet for example can lead to obesity, diabetes, cancers, and dental caries. Hence, nutritionists, diabetologists, oncologists, dental practitioners can work together with diet as common theme. A modified form of this approach ( Figure 3 ) can be a useful tool in engaging other health promoters, in tackling the different forms of disease, and in propagating the ideals of medicinal plants. Working with various groups, for example, appropriate medicinal plants can be incorporated into the diets to alleviate disease and suffering. This approach will enable those working to promote the use of medicinal plants to collaborate with other health promoters in areas such as malaria, diabetes, cancers, cardiovascular diseases, tuberculosis, HIV/AIDS, oral diseases, dermatological problems, etc.
Behavioural Risk Factors
Incorporating the oral health promotion model as outlined in the Ottawa charter will also be useful. 
The Primary Health Care (PHC) Approach
Primary Health Care was defined in Alma Ata (WHO, 1978) as essential care based on practical, scientifically sound and socially acceptable method and technology made universally accessible to individuals and families in the community through their full participation and at a cost they and the country can afford to maintain in the spirit of selfreliance and self-determination. The PHC philosophy recognises that each discipline contributes to health and health services delivery within a PHC model, both in a unique sense and through collaborative interdisciplinary practice.
The five core principles of the PHC approach include the following: -Equitable distribution -Community Participation (as issues that local people identify rather than predetermined services introduced by professionals, working within existing community organisations and local government structures, etc. Multisectoral Approach -Emphasis should be made that the reason for the failure of many programmes is due to the fact that they operate in isolation, separate from the general health care structure and without the support of other relevant sectors. The need for programme cooperation and collaboration cannot be over-emphasised.
The elements (or components) of PHC include (but not limited to) Immunisation, Maternal and Child Health (MCH) Care, Essential Drugs, Food and Nutrition, Education, Common Illnesses and injury, Water and Sanitation, Endemic Infectious Diseases, Mental health and Oral health.
All African countries have adopted PHC as the over-arching strategy to achieve health for their citizens. Strategies for the promotion of medicinal plants for the prevention of diseases in Africa must therefore take into cognisance the PHC approach. It must essentially follow the 5-key principles outlined above and be integrated into the elements. Medicinal plants will be useful for Maternal and Child health care, as essential drugs, in food and nutrition, for common illnesses and injury, for endemic infectious diseases, mental health and oral health.
Medicinal In summary, from the above considerations of available strategies, medicinal plants can play vital roles in disease prevention and their promotion and use fit into all existing prevention strategies. However, conscious efforts need to be made to properly identify, recognise and position medicinal plants in the design and implementation of these strategies. These approaches present interesting and emerging perspectives in the field of medicinal plants.
Ethnobotanical Studies on Medicinal Plants Used in Disease Prevention
In order that a comprehensive compilation of medicinal plants that can be used in disease prevention is obtained, collation of original data from the traditional custodians of such knowledge is essential (Tan et al., 2010) . This is especially so in the case of African Traditional Medicine (ATM) where information is passed on from generation to generation orally about the plants used. Unlike in Chinese Traditional Medicine (CTM) and the Indian systems of medicine (Ayurveda, Unani and Sithda) where the information is available in books (and now online), a lot of the information on African traditional medicine is yet to be documented. Efforts are, however, being made by WHO-AFRO to augment the various isolated databases on medicinal plants through the provision of guidelines for documentation of herbal recipes (WHO/AFRO 2012). Specific ethnobotanic surveys at village level using some of the methods described by Sofowora (2008) 2011) among the Chakma residents of Hatimara (south) village of Rangamati district, also in Bangladesh, indicated that the mode of consumption of the plants differed to some extent. Some plants, like Spilanthes calva or Commelina paludosa, the leaves were boiled, mixed with crushed peppers and taken. The authors found that the addition of peppers did not serve any therapeutic purposes. Rather, peppers, particularly hot peppers, were added to make the dish more palatable and to impart flavour to the dish (Rahmatullah et al., 2009; Sofowora 2008; Abel and Busia, 2005) . The juice of young leaves of Centella asiatica or juice of leaves of Solena amplexicaulis was taken in the raw state. The fruits of Gymnopetalum cochinchinense were used for prevention of ulcer, and Solanum torvum as a preventive measure against leucorrhoea, typhoid and tonsillitis. The barks and seeds of Saraca were mashed and taken in the raw state as prevention for irregular menstruation and menorrhagia.
International ethnobotanical surveys sponsored by ACCT (Agence de Cooperation Culturelle et Technique) into 17 Francophone African countries and 5 into Anglophone African countries sponsored by the African Union (AU/STRC) and most of which were led by Professor Edouard Adjanohoun (Benin now France) and Professor Laurent Ake Assi have been published. These need to be searched for plants used in disease prevention as they were general ethnobotanic surveys which probably emphasised more enquiries on the use of plants to treat disease. All the data from such surveys especially the new ones need to be stored in a database where it is not yet done and protected for only authorised access.
Medicinal plants used to prevent cancer
Yasukawa (2012) has reviewed the chemopreventive activity of natural sources, foods, supplements, crude drugs and Kampo medicines (traditional Japanese herbal prescriptions). In that review, he observed that cancer chemoprevention is currently one of the most urgent projects in public health. Cancer chemoprevention is defined as the use of specific natural and synthetic chemical agents to reverse or suppress carcinogenesis and prevent the development of invasive cancers. Recently, dietary non-nutrient compounds have demonstrated important effects as chemo-preventive agents, and considerable work on the cancer chemopreventive effects of such compounds in animal models has been undertaken. Epidemiological surveys have shown that the majority of human cancers are related to two factors, namely, diet and smoking (Banning, 2005; Hirayama, 1984) . However, in the general population, daily consumption of certain foods has also been shown to have anticancer effects. This highlights the importance of environmental factors such as diet in cancer chemoprevention (Banning, 2005 ). An understanding of the mechanisms of carcinogenesis is essential for cancer chemoprevention. In contrast to both the initiation and progression stages, animal studies have indicated that the promotion stage occurs over a long time period and may be reversible, at least early on. For this reason, it is expected that inhibition of tumour promotion should be an efficient approach to cancer control (Murakami, et al., 1996) . Yasukawa and his team have found in the search for potential anti-tumour promoters (cancer chemopreventive agents) from edible plants and fungi, and from crude drugs, that various triterpene alcohols and sterols and their oxygenated derivatives showed inhibitory effects on mouse ear inflammation induced by 12-Otetradecanoylphorbol-13-acetate (TPA). Primary prevention of cancer aims to avoid the development of cancer. Therefore, initiation and/or promotion of carcinogenesis should be inhibited. However, the adult population bears tumour cells that cannot revert to normal cells, and thus effective strategies to prevent cancer include avoiding continuous contact between these cells and promoters and/or aggressively inhibiting the tumour promoter effects. Therefore, to prevent cancer, it is essential to find plants that contain effective compounds (anti-tumour promoters) that delay, inhibit or block tumour promotion, which is a reversible and long-term process (Yasukawa, 2012) . 
reduction (P = 0.034) in prostate cancer incidence (35%) compared to casein fed mice (62.5%). P. africanum therefore has a significant role in regulation of prostate cancer both in vitro and in vivo and therefore may be a useful supplement for people at high risk for developing prostate cancer (Shenouda et al, 2007) . Katz (2002) had observed that the consumption of isoflavones found in legumes and other plants is related to lower rates of BPH and prostate cancer among Asian men (Katz, 2002) . The methanol extract of Prunus jamasakura Sieb. ex Koidz. inhibited two-stage carcinogenesis by DMBA/TPA in mouse skin (Yasukawa, et al., 1998) . Octacosyl ferulate, from the active fraction of the plant, inhibited tumour promotion by DMBA/TPA in mouse skin (Yasukawa, et al., 1998) (Figure 7) . The compound also inhibited the phosphorylation of histone by protein kinase C (PKC) in a concentration-dependent manner. They reported a significant reduction in tumour incidence (33%), tumour multiplicity (42%), and increase in survival (34%) upon administration of the aqueous extract to NDEA-abused mice. Transmission and scanning electron microscopic investigations showed severe alterations in organelle organisation, cellular arrangement, degree of differentiation, cellular metabolism, and morphology of the hepatocytes. They concluded that these changes appeared to be distinctly delayed upon supplementation with the leaf extract of the plant. The results suggest that A. indica may have anticancer potential against NDEA-induced hepatic cancer.
Rosmarinus officinalis L (Family Labiatae) Rosemary
Colorectal cancer is the second leading cause of cancer death in Australia. Ngo et al. (2011) reviewed scientific evidence from all studies published from 1996 to March 2010 and which examined the protective effects of rosemary on colorectal cancer and other types of cancer. They concluded that evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract as well as only the following constituents of it: carnosol, carnosic acid, ursolic acid, and rosmarinic acid. The reported anticancer properties were found to arise through the molecular changes in the multiple-stage process of cancer development, which are dose related and not tissue or species specific. López-Jiménez (2013) demonstrated that the anti-angiogenic activity of carnosol and carnosic acid could contribute to the chemopreventive, antitumoral and antimetastatic activities of rosemary extracts and suggested their potential in the treatment of other angiogenesis-related malignancies. Ursolic acid and carnosol were isolated from the methanol extract of Rosemary, and inhibited DMBA/TPA-promoted two-stage carcinogenesis in mouse skin (Huang et al., 1994) (Figure 8 ). against a broad range of cancer cells by targeting epidermal growth factor receptor (EGFR) and its downstream pathways, inhibiting over-expression of COX-2 and prostaglandin E2 receptors, or modifying oestrogen receptor pathways, resulting in cell cycle arrest and apoptosis (Zhou and Raffoul, 2012) . Filip et al. (2011) in their studies on Photoprotective effects of two natural products on ultraviolet B-induced oxidative stress and apoptosis in SKH-1 mouse skin reported that their results suggest that Calluna vulgaris and Vitis vinifera extracts might be chemopreventive candidates for reducing UV-induced risk for skin cancer.
Currants and Sultanas (Vitis vinifera L.) are dried vine products produced in Greece. Kaliora et al. (2008) investigated the gastric cancer preventive activity of methanol extracts obtained from currants from three different origins in Greece (Vostizza, Nemea, and Messinia), as well as methanol extracts obtained from Sultanas cultivated on the island of Crete as to inhibition of cell proliferation, induction of apoptosis, and inhibition of inflammation. All extracts from 500 micrograms of dried raisins studied suppressed cell proliferation, significantly those obtained from Sultanas from Crete and currants from Nemea. The French eat higher levels of animal fat, but their incidence of heart disease remains surprisingly low. This 'French Paradox' is thought to be due to the benefits they derive from consuming red wine. The ethanol extract of grapes inhibited tumour promotion by DMBA/TPA in mouse skin (Alam et al., 2002) . Resveratrol, in a dose-dependent manner, reduced the incidence, total number and multiplicity of visible hepatocyte nodules (Bishayee and Dhir, 2009) ( Figure  9 ). 
Glycine max or G. soya (Family Leguminosae) Soya milk
Genistein, the most abundant phytoestrogen in soybeans, may bind to oestrogen receptors and perform anticancer activities. Choriocarcinoma is a malignant, trophoblastic and aggressive cancer of the placenta. Liu et al (2011) investigated the effect of genistein on the invasive potential of the choriocarcinoma cell line JAR and its underlying mechanism and found that genistein inhibited JAR cell invasion in a dose-dependent manner by a matrigel invasion assay. Their findings have significant implications for the prevention and therapy of choriocarcinoma. However, Khan et al (2012) tested the hypothesis that Soy isoflavone consumption may protect against breast cancer development. They found a lack of efficacy for breast cancer prevention and a possible adverse effect in premenopausal women. Soy milk inhibited 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanoneinduced mammary carcinogenesis in rats (Ohta et al., 2000) . Soy beans contain high amounts of isoflavonoids and saponins; isoflavonoids have been shown to have phytoestrogenic activity (Moliteni et al., 1995; Katz, 2002) .
Zingiber officinale Roscoe (Family Zingiberaceae) Ginger
Dehydrozingerone a pungent constituent of ginger is a vanillyl ketone. Structurally, it is representative of half the chemical structure of curcumin which is a promising phytochemical for the inhibition of malignant tumours, including colon cancer. Yogosawa et al. (2012) evaluated the antiproliferative effects of dehydrozingerone against HT-29 human colon cancer cells, and it was found that it dose-dependently inhibited growth at the G2/M phase with up-regulation of p21. Dehydrozingerone additionally led to the accumulation of intracellular ROS, although most radical scavengers could not clearly repress the cell-cycle arrest at the G2/M phase. Their results suggest that analogues of dehydrozingerone may be potential chemotherapeutic agents for colon cancer (Škrovánková, 2012) . Kurapati et al. (2012) investigated the combinatorial cytotoxic effects of Curcuma longa and Zingiber officinale on the PC-3M prostate cancer cell line. The two extracts separately showed significant inhibitory effects on colony-forming ability. However, when both the agents were tested together at the same concentrations, the combined effects were much more significant than their individual ones, suggesting the role of multiple components and their synergistic mode of actions to elicit stronger beneficial effects.
Hexahydrocurcumin, extracted from Zingiber officinale, was shown to be cytotoxic to colorectal cancer cells by Chen et al. (2011) . Treatment of SW480 cells with hexahydrocurcumin (100 microM) resulted in a massive accumulation of the cells in the G1/G0 phase of the cell cycle. This compound could prove useful in cancer prevention.
The protective and/or preventive activity of various spices against various cancers and gastric ulcer has been reviewed by Sumbul et al. (2011) and by Sung et al. (2012) .
Topical application of an ethanol extract of ginger inhibited TPA-induced tumour promotion during two-stage carcinogenesis in mouse skin (Katiyar et al., 1996) . Pre-application of an ethanol extract of ginger onto the skin of SENCAR Onion oil inhibited tumour promotion by DMBA/TPA (Belman, 1983; Perchellt et al., 1990) and by BP/croton oil (Sadhana et al., 1988) in mouse skin, while garlic oil inhibited tumour promotion by DMBA/TPA in mouse skin (Belman, 1983; Perchellt et al., 1990) . Kang et al. (2011) found that it inhibited breast cancer cell proliferation and inhibited both anchorage-dependent and -independent breast cancer cell colony formation. In addition, Rp1 induced cycle arrest and apoptosis-mediated cell growth suppression. Rp1 also decreased the stability of the IGF-1R protein in breast cancer cells. They therefore suggested that Rp1 has potential as an anticancer drug and that IGF-1R is an important target for treatment and prevention of breast cancer. In their own studies, Cui et al. (2010) found that when American ginseng was tested using the azoxymethane (AOM)/dextran sulphate sodium (DSS) mouse model of ulcerative colitis, they demonstrated that ginseng can suppress colon cancer associated with colitis.
Panax ginseng C.A. Mayer (Family Araliaceae). Ginseng
Oral administration of white and red ginseng (Panax ginseng C.A. Mayer) suppressed colon carcinogenesis by 1,2-dimethylhydrazine (DMH) in rat (Fukushima, et al.,2001 ). The ginsenosides Rg3, Rg5 and Rh2 are active components in ginseng, and act either singularly or synergistically in cancer prevention (Yun, et al., 2001 ). The methanol extract of san-chi ginseng (P. notoginseng (Burk.) F.H. Chen) suppressed skin carcinogenesis by DMBA/TPA, liver carcinogenesis by DEN/Phenobarbital, lung carcinogenesis by 4NQO/glycerol in mice (Konoshima et al., 1996) . Moreover, the methanol extract of san-chi inhibited skin carcinogenesis by NOR-1/TPA, as well as DMBA/fumonisin B1 in mice (Konoshima et al., 1999) . The ginsenoside Rg1 slightly suppressed tumour promotion by DMBA/TPA in mouse skin (Konoshima et al., 1996) (Figure 11 ).
Figure 11: Ginsenosides from Ginseng
Prevention and treatment of male osteoporosis due to androgen deficiency by using the medicinal plant: Eurycoma longifolia Osteoporosis in elderly men is now becoming an alarming health issue due to its relation with a higher mortality rate compared to osteoporosis in women. Androgen deficiency (hypogonadism) is one of the major factors of male osteoporosis and it can be treated with testosterone replacement therapy (TRT). However, one medicinal plant, Eurycoma longifolia Jack (EL), can be used as an alternative treatment to prevent and treat male osteoporosis without causing the side effects associated with TRT. EL exerts proandrogenic effects that enhance testosterone level, as well as stimulate osteoblast proliferation and osteoclast apoptosis. This will maintain bone remodelling activity and reduce bone loss. Phytochemical components of EL may also prevent osteoporosis via its antioxidative property (Figure 12 ). Hence, EL has the potential as a complementary treatment for male osteoporosis (Effendy et al., 2012) . 
Plants used for the prevention of Coronary Heart Disease (CHD)
Coronary Heart Disease (CHD) is the primary contributor to morbidity and mortality worldwide. A great deal of research is now focused on identifying new therapeutic alternatives to prevent and treat CHD. The most consistent recommendations from a Public Health perspective involve multiple changes in diet and exercise. Medicinal plants are also a viable option for its prevention and treatment. Clinical and preclinical data on some medicinal plants used as dietary supplements show that they may be useful in the strategies to reduce the prevalence and mortality of CHD either in the general population or in the subsets of individuals at high risk. Such plants include, for example, artichoke, garlic, gingko, guggul, hawthorn and tea.
Artichoke Cynara scolymus L. (Family Asteraceae)
Dried leaves and lower part of the flower of this plant contain 6% phenolic acids, 5% sequiterpene latones. Three sesquiterpenes, cynaropicrin, aguerine B, and grosheimin were isolated as the active components of the artichoke extract which reduced serum triglyceride levels in olive oil-loaded mice. Aqueous and ethanolic extracts of artichoke also reduced intracellular oxidative stress stimulated by inflammatory mediators such as tumour necrosis factor alpha (TNFa) and lipopolysacchaide (LPS), as well as ox-low density lipoprotein (ox-LDL) in endothelial cells and monocytes.
Garlic (Alium sativum, (Family Liliaceae)
Over 35 randomised clinical trials on garlic were carried out to investigate the effect of garlic on cardiovascular end points. Overall, there is evidence from randomised controlled trials (RCT) in adults that the use of garlic preparations can lead to a small but statistically significant reduction in total cholesterol levels compared with controls.
Guggul Commiphora mukul.(Jacq) Engler,(Family Burseraceae)
The Mukul Myrrh tree has been used as far back as 600 BC. According to the recent WHO Monograph for guggul, the plant is useful for the treatment of hyperlipideamia and hypercholesterolemia. The plant sterols, E-and Z-guggulesterone, are believed to be the bioactive compounds.
Strategies for combating micronutrient deficiencies: Food-based approaches
Multiple micronutrient deficiencies abound in developing countries (Ramakrishnan, 2002) . They are caused by inadequate intakes but genetic, parasitic and infectious diseases may also play a role (Fishman, et al., 2000; Stoltzfus, 2001 ). Micro nutrient deficiencies can have major adverse health consequences, contributing to impairment in growth, immune competence, mental and physical development, and poor reproductive outcomes (Viteri and Gonzales, 2002 ) that cannot always be reversed by nutrition interventions. Inadequate intakes of certain micronutrients such as iodine, selenium and zinc can also be exacerbated by environmental factors, as their content in plant based foods is dependent on soil trace elements (Gibson and Hotz, 2001) .
There is therefore a strong need for strategies to reduce micronutrient deficiencies in developing countries. Strategies commonly used are supplementation and food-based approaches, preferably in conjunction with public health interventions such as promotion and support of breast feeding and control of infectious and parasitic diseases. Fruits and vegetables are a good source of vitamins and minerals. Faber and Laurie (2011) described a home garden strategy that integrates gardening activities with nutrition education, using community based growth monitoring as an entry point in South Africa. A positive effect was observed that Provitamin A rich vegetables and fruits contributed significantly towards achieving the recommended dietary intake of Vitamin A and other micronutrients. They concluded that home gardening is a long term strategy that contributes to combating Vitamin A and other nutritional deficiencies. This is only one of the several individual investigations reported by Thompson and Amoroso (2011) to pinpoint the fact that food based strategies are viable, sustainable and long term solutions to overcoming micronutrient malnutrition.
The strategy of using antioxidant activity of medicinal plants in prevention of diseases
Oxidative stress, caused by reactive oxygen species, plays an important role in many chronic and degenerative diseases, such as atherosclerosis, ischemic heart disease, cancer, diabetes mellitus, neurodegenerative diseases and ageing (Azizova, 2002) . The body's non-enzymatic antioxidant defence system includes some antioxidants, such as vitamin C, vitamin E, vitamin K and glutathione. Some synthetic antioxidants, widely used in food industry to protect food from oxidation and spoiling, are harmful because of their potential toxicity and carcinogenicity (Botterweck et al., 2000) . However, natural antioxidants in fruits and vegetables are inversely related with the risk of the chronic diseases mentioned above (Leifert and Abeywardena, 2008) . Natural antioxidants, therefore, provide alternative strategy to prevention as well as treatment of these diseases. Phenolic compounds because of their oxidative activity are potential agents for preventing and treating many oxidative stress-related diseases. The antioxidant activity of polyphenols is mainly due to their redox properties, which allow them to act as reducing agents, hydrogen donors, singlet oxygen quenchers, metal chelators and reductants of ferryl hemoglobin (Kratchanova et al., 2010) . Some medicinal plants possess more potent antioxidant activity than common dietary plants (Cai et al., 2004) . Therefore, their extract, if not toxic, can serve as food additive and can be used for disease prevention (Liu, 2003; Liu et al., 2008) .
Oral Diseases prevention with medicinal plants
Oral diseases are major health problems with dental caries and periodontal diseases among the most prevalent, preventable global infectious diseases. Oral health influences the general quality of life and poor oral health is linked to chronic conditions and systemic diseases. The association between oral diseases and the oral microbiota is well established. Although there are more than 750 species of bacteria that inhabit the oral cavity, most are normal commensals and only a few are implicated in oral diseases. The development of dental caries involves acidogenic and aciduric Gram-positive bacteria (mutans streptococci, lactobacilli and actinomycetes). Periodontal diseases have been linked to anaerobic Gram-negative bacteria (Porphyromonas gingivalis, Actinobacillus, Prevotella and Fusobacterium). Given the incidence of oral disease, increased resistance by bacteria to antibiotics, adverse effects of some antibacterial agents currently used in dentistry and financial considerations in developing countries, there is a need for alternative prevention and treatment options that are safe, effective and economical. While several agents are commercially available, these chemicals can alter oral microbiota and have undesirable side-effects, including tooth staining. Hence, the search for alternative products continues and natural phytochemicals isolated from plants used as traditional medicines are considered as good alternatives. Palombo (2011) concluded that there is considerable evidence that plant extracts, essential oils and purified phytochemicals have the potential to be developed into agents that can be used as preventive or treatment therapies for oral diseases. While it is encouraging to see a number of clinical trials of such products, further studies of the safety and efficacy of these agents will be important to establish whether they offer therapeutic benefits, either alone or in combination with conventional therapies, that can help to reduce the overall burden of oral diseases worldwide. In particular, studies that address issues such as adequate statistical power, blinding, standardisation of extracts or purified compounds, and quality control would be of great value (Palombo, 2011) 
Some miscellaneous practices for the prevention of diseases with medicinal plants in Africa
According to Koumare (2008) repeated sore throat especially in children is often prevented in Mali and other African countries by using gargles made with the following plants: Spilanthes sp, Guiera senegalensis and Waltheria indica. Traore (1975) had also compiled some cultural practices of the Malian people in the prevention of dental problems with medicinal plants (Troure, 1975) . The efficacy of chewing sticks used for preventive dental care had been reported by Sofowora and others (Sofowora, 2008) . It is common knowledge among women in Africa, especially in Burkina Faso, to rub the skin of new borne babies with various medicinal plants (e.g. Pterocarpus osun) soaked in oil to prevent them from bacterial infection as they are carried by various people. Also, because the mothers do not know whether the visitors carrying the newborn have evil intentions, the preparation with which the baby is rubbed often contains plants with occult powers to ward off any spiritual attack on the baby by visitors. Various antenatal practices using medicinal plants exist in Africa. The pregnant woman is made to bathe in some decoctions of herbs and required to drink a little of it periodically throughout the period of pregnancy to sustain her. There are also herbs to be taken just before delivery to hasten or to ease delivery. However, the use of herbs in late pregnancy could be for their oxytocic properties. Some preparations for preventing road accidents exist in Africa just as there are similar preparations utilising the occult power of herbs to eject a person from an accident vehicle before the accident (Egbe in Yoruba). These latter preventive uses of medicinal plants involving the occult power of herbs may be beyond present capabilities of scientific experimentation to prove their efficacy.
Conclusions
Efforts must be geared towards measures that will enhance the effectiveness, efficacy and rational use of medicinal plants, especially through the integration into national, regional and local health policies and programmes. Most African countries, for example, hinge their health care system on the Primary Health Care (PHC) strategy and it is necessary to incorporate the use of medicinal plants into all the components of PHC in these countries. The following are also recommended: a) Collation of data from books, research articles, conducting of ethnobotanical surveys (because Africans have only recently started documentation of medicinal plants and their uses; oral tradition had been the mainstay) specifically to look for plants used in preventing diseases in our communities as was done in Muktipara village of Sri Lanka. Database searches on medicinal plants will also yield useful results (Table 1) ; b) collaborative research with Institutes for preventive medicine as well as departments of preventive dentistry in teaching hospitals; and c) coordination of the research to avoid duplication of efforts. 
